High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease-Reference-Cited by-同舟云学术

High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease

Published:2000-06 Issue:6 Volume:11 Page:665-672
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Argiris A.,Seropian S.,Cooper D.L.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/11/6/665/19478360/11-6-665.pdf

Reference27 articles.

1. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: The low probability for cure;Longo;J Clin Oncol,1992

2. Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD;Bonfante;J Clin Oncol,1997

3. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease. Results of a BNLI randomised trial;Linch;Lancet,1993

4. Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy;Reece;Blood,1994

5. High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy;Reece;Blood,1995

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic Cell Transplantation for Hodgkin Lymphoma;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

2. Comparison of efficacy and toxicity according to etoposide and cytarabine dosing in BEAM conditioning followed by autologous stem cell transplantation in Hodgkin lymphoma;Leukemia & Lymphoma;2023-08-24

3. Etoposide hypersensitivity reactions associated with in-line filter use: A retrospective cohort study at CHU de Québec-Université Laval;Journal of Oncology Pharmacy Practice;2022-12-21

4. A Cure Rate Survival Model after Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma Patients;MIDDLE EAST J CANCER;2022

5. Outcome of Children and Adolescents with Recurrent Classical Hodgkin Lymphoma: The Italian Experience;Cancers;2022-03-13